Abbott Richard David sold (to issuer) $3K of CODX
Abbott Richard David (President) sold (to issuer) 680 shares of Co-Diagnostics, Inc. (CODX) at $5.07 on 2026-05-23.
How this was made
The 30-second read
Why it matters
The filing documents an officer/direct sale to the issuer (680 shares) at $5.07 with holdings after the trade of 3,417 shares; it does not include any business update.
Market read
Primarily a sentiment/ownership-visibility datapoint; no fundamental catalyst is described.
What to watch
No 10b5-1 plan is disclosed, but the transaction is small; without additional insider activity or company fundamentals, signal-to-noise is low.
Background
The article is an SEC Form 4 insider transaction disclosure for Co-Diagnostics, Inc. (CODX).
Ticker impact
Co-Diagnostics officer Richard David Abbott sold 680 shares to the issuer at $5.07 via a Form 4, changing insider ownership visibility.
Low near-term impact; any reaction is likely limited to short-lived sentiment/flow effects rather than a thesis change.
Form 4 insider transactions are common and the filing provides no accompanying operational or financial catalyst; the disclosed size ($3.4k) is modest versus typical market moves.
Market effects
Minimal; no read-across catalyst (no trial, contract, or regulatory action) is provided.
None indicated.
None indicated.
Counterpoint
The sale-to-issuer code (D) can reflect administrative liquidity or buyback participation rather than bearish intent, so price impact may be overstated.
Key entities
- issuerCo-Diagnostics, Inc.
Subject of the Form 4 insider transaction; officer Richard David Abbott sold 680 shares to the issuer.
- insiderAbbott Richard David
President of Co-Diagnostics; reported sale to issuer on 2026-05-23.
